Is L-carnitine approved or legal?

Yes, in a specific form: levocarnitine (Carnitor) is an FDA-approved prescription drug for primary and secondary carnitine deficiency, and L-carnitine is also sold as a dietary supplement. Research/injectable material sold outside the approved drug supply is unregulated and labeled for research use only.

Does L-carnitine actually burn fat?

It is required for the body to use fat for energy, but simply taking more does not reliably cause fat loss in healthy, carnitine-replete people. Controlled trials are mixed; the 'fat-burning injection' marketing is stronger than the human evidence. Any benefit appears greatest alongside consistent training and a calorie deficit.

What dose and how often is used, and what is the half-life?

Supplement studies most often use ~1-4 g/day orally (often L-carnitine L-tartrate) for several weeks; approved injectable dosing is condition-specific and physician-directed. Plasma half-life is short (about 60 minutes), though tissue stores turn over slowly. This is reference information, not dosing advice.

What is the best-supported benefit?

Outside true deficiency, the most reproducible findings are modestly faster exercise recovery and reduced muscle-damage/soreness markers after several weeks of use, plus clinical benefits (lipids, anemia, quality of life) in dialysis patients.

It is generally well tolerated. Side effects include GI upset, a fishy body odour at high doses, and injection-site irritation. Use caution with kidney impairment (renal clearance/accumulation) and thyroid conditions; a gut-bacteria metabolite (TMAO) has been linked in some observational studies to cardiovascular risk. Not a recommendation for human use.

Metabolic

L-Carnitine

Also known as: Levocarnitine, Carnitor, L-Carnitine L-Tartrate, LCLT

A naturally occurring amino-acid derivative that carries fatty acids into mitochondria for energy. An approved drug for carnitine deficiency; evidence for fat loss is mixed.

Last updated July 11, 2026

Buy L-Carnitine

Overview

L-carnitine is a compound synthesised in the body from the amino acids lysine and methionine and also obtained from the diet (mainly red meat). Its core physiological job is to transport long-chain fatty acids across the inner mitochondrial membrane so they can be oxidised for energy. Because of that role it is marketed for fat loss, energy, and exercise recovery, and is frequently offered as an intramuscular or intravenous "lipotropic" injection. It is important to separate two contexts. As the prescription drug levocarnitine (Carnitor), L-carnitine is FDA-approved and well-evidenced for primary and secondary carnitine deficiency, including in dialysis patients. As a performance/aesthetic supplement in people who are not deficient, the evidence is far weaker and inconsistent — roughly two decades of athletic-performance studies have not produced convincing, repeatable benefits for body composition or weight loss in healthy individuals. Material sold for research/injection outside the approved drug supply is unregulated, and the "fat-burning injection" marketing around it outpaces the human data. This entry summarises the science for reference only; it is not medical advice and does not endorse human use.

How it works

L-carnitine is the obligatory carrier in the carnitine shuttle: carnitine palmitoyltransferase I (CPT1) conjugates it to long-chain acyl-CoA to form acylcarnitine, which crosses the inner mitochondrial membrane via the carnitine-acylcarnitine translocase, where CPT2 regenerates acyl-CoA for beta-oxidation. By increasing fatty-acid flux into mitochondria it can, in principle, raise fat utilisation for fuel. It also buffers the mitochondrial acyl-CoA/CoA ratio and may reduce exercise-induced oxidative stress and markers of muscle damage. A key limitation for the supplement claims is that skeletal-muscle carnitine content is tightly regulated and not easily raised by extra intake in carnitine-replete people, which helps explain the modest and inconsistent functional effects.

Researched effects

Clinical Corrects primary and secondary carnitine deficiency (approved drug indication)
Clinical Improves lipid profile, anemia and quality of life in hemodialysis patients
Clinical Speeds exercise recovery and reduces muscle soreness/damage markers with weeks of use
Clinical May protect against contrast-induced nephropathy and certain drug toxicities
Anecdotal Enhances fat oxidation and supports fat loss when combined with training
Anecdotal Boosts energy and athletic performance in healthy users

Evidence levels: Clinical (human trials) · Preclinical (animal/lab) · Anecdotal (community-reported).

Dosing reference

For research reference only — not a recommendation.

Clinical / studied dosing

As the approved drug levocarnitine, dosing is condition-specific and physician-directed (e.g., oral 990 mg two to three times daily, or intravenous dosing in dialysis-associated deficiency). Recovery and metabolic supplement studies have most often used roughly 1-4 g/day orally (frequently as L-carnitine L-tartrate) for several weeks. There is no established or approved dose for cosmetic "fat-loss" injections.

Community-reported dosing (anecdotal)

Anecdotal and research-reference only; not medical advice. Community and clinic protocols commonly describe intramuscular or subcutaneous injections of roughly 200-500 mg per dose (some clinics use higher IV doses), taken before training or several times per week, often alongside other "lipotropic" ingredients. Oral L-carnitine L-tartrate at 1-2 g/day is the more evidence-aligned route. These figures reflect unverified community practice, not tested-safe or effective injection doses.

Half-life: Short. After a 2 g oral dose in healthy volunteers the elimination half-life of L-carnitine was about 60 minutes; intravenous pharmacokinetic studies (e.g., 20 mg/kg IV) give comparable short plasma half-lives, with renal handling (including saturable tubular reabsorption) governing clearance. Tissue carnitine pools turn over far more slowly than plasma levels suggest.
Routes: intramuscular, intravenous, subcutaneous, oral

Safety & side effects

L-carnitine is generally well tolerated; oral use is considered likely safe for up to about 12 months, and injectable levocarnitine is an established prescription product. Common adverse effects include nausea, vomiting, stomach upset, heartburn, diarrhoea, and a characteristic fishy body odour at higher doses; injection-site irritation can occur with injections. Caution is warranted in renal impairment (carnitine is cleared renally and accumulates), and high doses may interfere with thyroid hormone action and lower seizure threshold in susceptible people. A separate, debated concern is that gut bacteria convert carnitine to TMAO, a metabolite associated in some observational research with cardiovascular risk. Research-grade injectable material is unregulated and may be impure or mislabelled. This is reference information, not a recommendation for human use.

Research summary

L-carnitine has a strong, well-defined biochemical role and genuine approved clinical uses in carnitine-deficiency states and dialysis populations, where randomized data support benefits on lipids, anaemia, and quality of life. Outside those settings the picture is weaker: meta-analyses and reviews of athletic and weight-loss use are inconsistent, with the most reproducible non-deficiency finding being modest improvement in exercise recovery and reduced muscle-damage markers after several weeks of supplementation. The popular "fat-burning injection" positioning is not well supported by controlled human trials in healthy people, partly because muscle carnitine is hard to raise in replete individuals. Pharmacokinetics are well characterised (short plasma half-life, renal clearance). Overall it is a low-risk, biologically plausible compound whose marketed aesthetic/performance benefits exceed the current evidence.

FAQ

Is L-carnitine approved or legal?: Yes, in a specific form: levocarnitine (Carnitor) is an FDA-approved prescription drug for primary and secondary carnitine deficiency, and L-carnitine is also sold as a dietary supplement. Research/injectable material sold outside the approved drug supply is unregulated and labeled for research use only.
Does L-carnitine actually burn fat?: It is required for the body to use fat for energy, but simply taking more does not reliably cause fat loss in healthy, carnitine-replete people. Controlled trials are mixed; the 'fat-burning injection' marketing is stronger than the human evidence. Any benefit appears greatest alongside consistent training and a calorie deficit.
What dose and how often is used, and what is the half-life?: Supplement studies most often use ~1-4 g/day orally (often L-carnitine L-tartrate) for several weeks; approved injectable dosing is condition-specific and physician-directed. Plasma half-life is short (about 60 minutes), though tissue stores turn over slowly. This is reference information, not dosing advice.
What is the best-supported benefit?: Outside true deficiency, the most reproducible findings are modestly faster exercise recovery and reduced muscle-damage/soreness markers after several weeks of use, plus clinical benefits (lipids, anemia, quality of life) in dialysis patients.
Is it safe?: It is generally well tolerated. Side effects include GI upset, a fishy body odour at high doses, and injection-site irritation. Use caution with kidney impairment (renal clearance/accumulation) and thyroid conditions; a gut-bacteria metabolite (TMAO) has been linked in some observational studies to cardiovascular risk. Not a recommendation for human use.

References

All content is for research and educational use only and is not medical advice. Products are sold for laboratory research only and are not for human consumption.